3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat.
Saved in:
| Title: | 3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat. |
|---|---|
| Authors: | Chen KY; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, 110, Taiwan.; Neuroscience Research Center, Taipei Medical University, Taipei, 110, Taiwan., Hsueh SC; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, 21224, USA., Parekh P; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, 21224, USA., Batsaikhan B; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, 21224, USA., Tweedie D; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, 21224, USA., Luo W; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, 21224, USA., Patel C; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, 21224, USA., Chiang YH; Neuroscience Research Center, Taipei Medical University, Taipei, 110, Taiwan.; Department of Neurosurgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan., Bambakidis N; Department of Neurosurgery, University Hospitals of Cleveland, Cleveland, OH, 44106, USA., Hoffer BJ; Department of Neurosurgery, University Hospitals of Cleveland, Cleveland, OH, 44106, USA., Huang CZ; Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei, 110, Taiwan., Yu SJ; Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, 35053, Taiwan., Wu KJ; School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan., Wang Y; Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, 35053, Taiwan., Hong E; Aevis Bio Inc, Daejeon, 34141, Republic of Korea., Kim DS; Aevis Bio Inc, Daejeon, 34141, Republic of Korea. dskim@aevisbio.com.; Aevisbio Inc, Gaithersburg, MD, 20878, USA. dskim@aevisbio.com., Greig NH; Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, NIH, Baltimore, MD, 21224, USA. Greign@grc.nia.nih.gov. |
| Source: | GeroScience [Geroscience] 2025 Aug; Vol. 47 (4), pp. 5763-5783. Date of Electronic Publication: 2025 Mar 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2509-2723 |
|---|---|
| DOI: | 10.1007/s11357-025-01573-1 |
